Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Manufacturer Most Favored Nation Deals: How They Could Be Protected From 340B
Oct 15 2025
•
By
Cathy Kelly
MFN and DTC commitments most likely will be sheltered from 340B liability.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Pricing Debate
More from Market Access